Xcout Intel
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. is a next-generation gene editing company focused on discovering and developing precise genetic medicines for rare and complex diseases.
Subscribe to see Arbor Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Arbor Biotechnologies, Inc. at a glance
Arbor Biotechnologies, Inc. is a biotechnology company headquartered in United States. It has raised at least $304.5M across the 3 funding rounds on record. Its most recent funding round, Series C-2, raised $73.9M in March 2025. Xcout tracks 2 named people at Arbor Biotechnologies, Inc., including David Scott (co-founder).
Arbor Biotechnologies, Inc. leadership
- David Scottco-founder
- Feng Zhangco-founder
Arbor Biotechnologies, Inc. funding rounds
At least $304.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C-2 | $73.9M | 3 named | |
| Series C | $215M | 14 named | |
| Series A | $15.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Arbor Biotechnologies, Inc. competitors
A few of Arbor Biotechnologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Get Arbor Biotechnologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Arbor Biotechnologies, Inc. in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access